EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Longitudinal Patterns of Chronic Hepatitis B Care and Treatment Adherence in Australia: A National Linked Data Cohort Study

Jennifer H MacLachlan iD, Nicole Romero, Stacey L Rowe iD, Nicole Allard iD, Benjamin C Cowie iD

Journal of Viral Hepatitis · 2026-08 · 33 (8)

DOI: 10.1111/jvh.70207 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 09.07.2026. Verfasst von Jennifer H MacLachlan und 4 weiteren Autor:innen. Beteiligte Einrichtung: WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Antiviral Agents, Drug Monitoring, Hepatitis B, Chronic, Treatment Adherence and Compliance. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Australian Government Department of Health, Disability and Ageing, Department of Health, Disability and Ageing.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current uptake of chronic hepatitis B (CHB) treatment and care in Australia is well below target levels, leading to an ongoing burden of preventable liver disease and cancer. Understanding individual‐level trajectories of care engagement and variation by sociodemographic factors is essential to guide efforts to improve access to and retention in care. This study analysed records of hepatitis B viral load (VL) testing and antiviral treatment provided through Australia's national health insurance system, which were linked to migration, death, and sociodemographic data from various government datasets. Treatment and VL testing by population group were assessed, and uptake was calculated using modelled estimates of the number living with CHB. VL testing frequency and treatment adherence based on scripts dispensed were also assessed. Of the estimated 219,800 people living with CHB in Australia in 2023, 118,334 (53.8%) received either VL testing or treatment during 2014–2023. Estimated uptake of VL testing and treatment uptake were lower among Aboriginal and Torres Strait Islander people and also varied by region of birth. Of the 81,360 who received any VL testing, only 17,352 (21.3%) received it regularly, while 31,715 (39.0%) had evidence of prior monitoring but no VL testing since 2019. The majority of those who initiated treatment continued therapy and received supply sufficient for adherence. This study shows that substantial gaps exist in CHB care in Australia, particularly in continued monitoring among those not on treatment. Disparities in uptake are evident by priority population. Re‐engaging those lost to follow‐up should be prioritised.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsDrug MonitoringHepatitis B, ChronicTreatment Adherence and ComplianceAdolescentAdultAgedFemaleHumansMaleMiddle AgedYoung AdultAustraliaAustralian Aboriginal and Torres Strait Islander PeoplesCohort StudiesLongitudinal StudiesViral Load

Stichwörter der Autor:innen

antiviral agentsaustraliachronic diseasesepidemiologyhepatitis B (chronic)medication adherencepopulation healthsocial determinants of healthuniversal health care

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Department of Infectious Diseases, University of Melbourne, Parkville, Victoria, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
  • Cohealth, Melbourne, Victoria, Australia.
  • Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia.

ORCID-Profile: Jennifer H MacLachlan, Stacey L Rowe, Nicole Allard, Benjamin C Cowie

Förderung

  • Australian Government Department of Health, Disability and Ageing
  • Department of Health, Disability and Ageing

Zitieren

APA

MacLachlan, J. H., Romero, N., Rowe, S. L., Allard, N., & Cowie, B. C. (2026). Longitudinal Patterns of Chronic Hepatitis B Care and Treatment Adherence in Australia: A National Linked Data Cohort Study. Journal of Viral Hepatitis, 33(8). https://doi.org/10.1111/jvh.70207

Vancouver

MacLachlan JH, Romero N, Rowe SL, Allard N, Cowie BC. Longitudinal Patterns of Chronic Hepatitis B Care and Treatment Adherence in Australia: A National Linked Data Cohort Study. Journal of Viral Hepatitis. 2026;33(8). doi:10.1111/jvh.70207

BibTeX
@article{MacLachlan2026,
  author = {MacLachlan, Jennifer H and Romero, Nicole and Rowe, Stacey L and Allard, Nicole and Cowie, Benjamin C},
  title = {Longitudinal Patterns of Chronic Hepatitis B Care and Treatment Adherence in Australia: A National Linked Data Cohort Study},
  journal = {Journal of Viral Hepatitis},
  year = {2026},
  volume = {33},
  number = {8},
  doi = {10.1111/jvh.70207}
}
Kostenlos starten →